102015-09-8Relevant academic research and scientific papers
SAR optimization studies on a novel series of 2-anilinopyrimidines as selective inhibitors against triple-negative breast cancer cell line MDA-MB-468
Jo, Jeyun,Kim, Heegyu,Oh, Ji Youn,Kim, Soyeong,Park, Yeong Hye,Choi, Hyeonjin,Jeong, Jee-Yeong,Jung, Young-Suk,Yun, Hwayoung
, (2019)
Triple-negative breast cancers (TNBCs) account for approximately 15% of breast cancer cases and exhibit an aggressive clinical behavior. In this study, we designed and synthesized two series of 2-anilinopyrimidines based on the structure of our previously
Novel Derivatives of 2-Anilinopyrimidine and Composition Comprising the Same
-
Paragraph 0064; 0265; 0268; 0270-0271, (2018/09/08)
The present invention relates to a 2-anilinopyrimidine derivative represented by chemical formula 1 and a composition containing the 2-anilinopyrimidine derivative as an active ingredient for preventing or treating cancer. According to the present inventi
